JAN 30, 2016 6:28 AM PST

Deleting USF1 Gene Prevents Mice from Gaining Weight

WRITTEN BY: Kara Marker
Cardiovascular disease affects millions of Americans every year, and its strongly linked to obesity. A new study from the University of Helsinki has made novel connections between a gene and weight loss in extensive mouse studies. A huge impact could be made on decreasing the prevalence of cardiovascular disease should this study’s findings be translated into a therapy for reducing body fat in obese people.
 
The team from Helsinki started with a gene called USF1 (Upstream Transcription Factor 1) because of its previous association with lower cholesterol and triglyceride levels in humans. To learn more about the role of USF1 in metabolic health, they removed the gene from mice and examined their blood lipid profile. This is what they found:
  • Low levels of triglycerides
  • High levels of HDL cholesterol (the “good” kind)
The above ratio of triglycerides to HDL cholesterol is unhealthily opposite in obese people, so the researchers were quickly excited about the potential of their findings of USF1 impact. Even more, the USF1 knock-out mice remained lean even after being fed a fatty diet. In comparison to control mice with perfectly normal USF1 expression, the two group ate and exercised the same amount, but the USF1 knock-out mice weighed half as much as the control mice.
 
With the next step in their research being identifying the characteristic of USF1 that results in weight loss in its absence, the team noticed that the USF1 knock-out mice were consuming increasing amounts of oxygen and subsequently producing more carbon dioxide, indicating their metabolic rate had increased after losing USF1 expression. Then, they were able to connect the heightened metabolism to “brown fat.”
 

 
Brown fat actually burns fat for the purpose of generating heat to protect mice from cold temperatures. Humans also have brown fat. When USF1 was missing, the brown fat in the knock-out mice burned fat and sugar even at room temperature, like an “efficient vacuum cleaner.”
 
In humans, the same researchers found a less active form of USF1 that has similar, if less drastic, effects on humans as on mice with the gene knocked out.
 
Further studies on USF1 inhibition in humans could greatly help people dealing with multiple health problems relating to obesity and type 2 diabetes.
 
 
Source: University of Helsinki
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
FDA Approves Non-Statin Drug to Lower Cholesterol
The US Food and Drug Administration (FDA) has approved a new drug that lowers cholesterol levels.The drug, known as Nexl ...
MAR 03, 2020
Cardiology
MAR 03, 2020
Irregular Sleep Patterns Double Heart Disease Risk
Researchers at Brigham and Women’s Hospital in Boston have found that going to sleep at different times each night ...
MAR 06, 2020
Cardiology
MAR 06, 2020
Sugary Drinks Increase Risk of Cardiovascular Disease
Researchers have found that adults who drink at least one sugary drink per day are at a greater risk of dyslipidemia (ha ...
MAR 11, 2020
Neuroscience
MAR 11, 2020
Categories of Memory Work Together to Form Abstract Thought
Indiana University New research from the University of Trento shows how areas of the brain work to recall complex semant ...
APR 07, 2020
Immunology
APR 07, 2020
Too Much Salt Is Bad for the Immune System
Excessive salt intake is associated with health consequences for more than just cardiovascular status; the immune system ...
MAY 08, 2020
Drug Discovery & Development
MAY 08, 2020
Cholesterol Drugs May Boost Healthy Gut Bacteria in Obese People
While statins have long been known for their efficacy in treating high cholesterol, until recently, there was no evidenc ...
Loading Comments...